These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6127980)

  • 21. Regulation and bioelectrical effects of cyclic adenosine monophosphate production in the ciliary epithelial bilayer.
    Horio B; Sears M; Mead A; Matsui H; Bausher L
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):607-12. PubMed ID: 8595960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphadenopathies and phenytoin.
    Bellido PD; Ciria MD; Mujals DR; Morell AR
    Lancet; 1977 Jun; 1(8026):1372-3. PubMed ID: 69096
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of potent agonists acting at an endogenous atypical beta3-adrenoceptor state that modulate lipolysis in rodent fat cells.
    Hamilton BS; Doods HN
    Eur J Pharmacol; 2008 Feb; 580(1-2):55-62. PubMed ID: 18031735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide mechanisms of nebivolol.
    Maffei A; Lembo G
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):317-27. PubMed ID: 19443516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drugs and the thyroid gland].
    Cramarossa L; D'Angelo D; Galassi A; Puletti M
    Clin Ter; 1987 Nov; 123(4):287-96. PubMed ID: 2902952
    [No Abstract]   [Full Text] [Related]  

  • 26. Anticonvulsant hypersensitivity syndrome.
    Vittorio CC; Muglia JJ
    Arch Intern Med; 1995 Nov; 155(21):2285-90. PubMed ID: 7487252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Angioimmunoblastic lymphadenopathy, chemically induced and in autoimmune diseases. A common immunopathologic mechanism?].
    Scolozzi R; Boccafogli A; Tocchetto M; Lanza M; Cavazzini L; Guidoboni CA; Vicentini L; Salmi R; Coletti M; Pansini R
    Recenti Prog Med; 1983 Dec; 74(12):1385-94. PubMed ID: 6608773
    [No Abstract]   [Full Text] [Related]  

  • 28. Syndrome mimicking histiocytic medullary reticulosis due to diphenylhydantion therapy.
    Hiçsönmez G; Ozme S; Bektaş S
    Turk J Pediatr; 1980; 22(1-2):28-31. PubMed ID: 7256887
    [No Abstract]   [Full Text] [Related]  

  • 29. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.
    Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC
    J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotype-dependent time course of lymphocyte beta 2-adrenergic receptor down-regulation.
    Bruck H; Leineweber K; Beilfuss A; Weber M; Heusch G; Philipp T; Brodde OE
    Clin Pharmacol Ther; 2003 Sep; 74(3):255-63. PubMed ID: 12966369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the relationship between aggregation and cyclic nucleotides in platelets treated with betaadrenoceptor blocking drugs.
    Nosál R; Jancinová V; Petríková M
    Gen Physiol Biophys; 1983 Oct; 2(5):353-62. PubMed ID: 6147296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of full and partial agonists with beta-adrenergic receptors on intact L6 muscle cells.
    Pittman RN; Molinoff PB
    Mol Pharmacol; 1983 Nov; 24(3):398-408. PubMed ID: 6138704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nebivolol: a beta blocker with vasodilator properties].
    Waeber B
    Praxis (Bern 1994); 2000 Apr; 89(15):631-3. PubMed ID: 10804847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Side-effects of beta-receptor blockaders on the skin].
    Hödl S
    Z Hautkr; 1983 Jan; 58(1):17-28. PubMed ID: 6131557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pseudo-lymphomas and lymphomas induced by hydantoins].
    Reiffers J
    Nouv Rev Fr Hematol (1978); 1978 Apr; 20(1):131-7. PubMed ID: 353727
    [No Abstract]   [Full Text] [Related]  

  • 36. Lymphadenopathy in children.
    Bedros AA; Mann JP
    Adv Pediatr; 1981; 28():341-76. PubMed ID: 7041562
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of beta-blockers as a cornerstone of cardiovascular therapy.
    Hollenberg NK
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):165S-168S. PubMed ID: 16373194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathway.
    Carie AE; Sebti SM
    Oncogene; 2007 May; 26(26):3777-88. PubMed ID: 17260025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenytoin in cutaneous medicine: its uses, mechanisms and side effects.
    Scheinfeld N
    Dermatol Online J; 2003 Aug; 9(3):6. PubMed ID: 12952753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute and chronic effects of antidepressant drugs on beta-adrenergic function in astrocytes in primary cultures: an indication of glial involvement in affective disorders?
    Hertz L; Richardson JS
    J Neurosci Res; 1983; 9(2):173-82. PubMed ID: 6302296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.